NCT07089654 · NOT YET RECRUITING

Evaluation of a PMT Rehabilitation Nursing Plan for the Older Adults With MCI to Promote Cognitive Health

This trial is testing a structured 12-week behavioral program called Psychomotor Therapy, or PMT, against standard rehabilitation care for older adults with mild cognitive impairment. PMT combines relaxation, breathing, facial, hand, and mental exercises. Researchers will measure changes in cognition, mood, and anxiety using standard rating scales. This is a Phase NA trial, meaning it is a practical intervention study rather than a drug efficacy or safety trial in the traditional sense.

You may qualify if

  • Older adults are aged 50 years and above.
  • Subjective cognitive complaints from the individual or caregiver.
  • Screening for MCI using the Mini-Cog scores between 0-2 ( SN Abayomi, 2024).
  • Basic language communication, listening, speaking, and understanding skills.
  • Ability to provide informed consent.

You're excluded if

  • Diagnosed with severe psychiatric conditions (e.g., schizophrenia, major depressive disorder).
  • It is at the end stage of important functional organ diseases, such as malignant tumors, cardiac failure, etc.
  • Limb dysfunction.
  • Diagnosed with dementia.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-08-27

View full record on ClinicalTrials.gov

All APOE4 clinical trials